Fatty Acid Supplements: Evidence and Comparison

What does this guide compare?

Omega-3 oils, specialty fats and phospholipids have different evidence.

This collection compares products discussed around one topic. It is not a protocol to take in full. Links to individual profiles appear after the article.

Which products are compared?

Fish Oil (EPA/DHA), Krill Oil, Algal Oil, Cod Liver Oil, Flaxseed Oil, Evening Primrose Oil, Borage Oil, CLA (Conjugated Linoleic Acid), MCT Oil, Phosphatidylserine, Phosphatidylcholine, Lecithin.

Individual profiles describe formulation, source-reported amounts, tolerability and interactions. Those details remain ingredient-specific. An amount studied alone is not automatically appropriate in a combination.

How do their roles differ?

EPA and DHA enter membrane lipids and can influence lipid mediators. Flaxseed oil principally supplies ALA, whose conversion to EPA and DHA is limited. MCT oils and phospholipids have different metabolic roles; neither is an interchangeable substitute for EPA/DHA. [1][2]

What does the research show?

Why is “omega-3” not a single intervention?

The composite included cardiovascular death, heart attack, stroke, coronary revascularization and unstable angina. These were not head-to-head trials of EPA versus EPA/DHA: populations, formulations, comparators and follow-up differed. They do not justify recreating a prescription amount with retail capsules. Both trials were industry-funded. [5], [6]

Heart-rhythm signals matter too: REDUCE-IT reported hospitalization for atrial fibrillation or flutter in 3.1% versus 2.1%; STRENGTH reported investigator-identified new atrial fibrillation in 2.2% versus 1.3%. Those are different outcomes, not directly comparable rates. [5], [6]

Omega-3 trials differ substantially by dose, formulation and baseline cardiovascular risk. Prescription EPA findings cannot simply be assigned to fish-oil, krill-oil or algal-oil bottles. In the 2025 DO-HEALTH post hoc analysis of 777 older adults, omega-3 treatment affected several methylation clocks. This exploratory surrogate finding did not demonstrate longer survival or validate a full longevity stack. [1][2]

An observational association, a laboratory finding and a perceived benefit answer different questions. Randomized trials need their comparator, duration and population kept in view. An inconclusive result does not establish that an effect is impossible; it limits the claim that can be made.

Which overlaps and risks matter?

Cautions and interactions

The EPA-plus-DHA content differs from total oil weight. Cod liver oil also adds vitamins A and D. High-dose cardiovascular trials have reported atrial fibrillation signals, and medication review remains relevant. Oxidation, storage and declared formulation matter; a larger oil capsule is not necessarily a larger studied exposure. [1][2]

A complete product list includes prescription medicines, nonprescription products and supplements. Combination formulas can conceal duplicate ingredients. Timing and spacing from a medicine should follow its labeling and pharmacist guidance; this collection does not supply a universal timetable.

Regulatory status

In the United States, FDA does not approve dietary supplements for safety and effectiveness before marketing. In Canada, a natural health product requires a product licence before sale; its NPN or DIN-HM must match the finished product. An ingredient name or inclusion in this collection does not establish that every product or claim is authorized. Authorization also does not validate the complete combination. [3], [4]

What should be recorded and how should changes be interpreted?

Doserly brings dose logs, symptoms and routine changes together. For this collection, useful observations include EPA/DHA amounts, formulation, tolerability, medication changes and clinician-interpreted lipid results.

• Doses and adherence: record the formulation, amount actually taken, timing and missed doses so observations have context.
• Potential benefits and tolerability: compare consistent symptoms or measurements over time alongside sleep, food and activity changes. Personal trends help evaluate the experience without proving causal efficacy.
• Product list: maintain the full product list for review with a pharmacist or clinician.
• AI monthly reports: summarize recorded doses, symptoms and trends to prepare for a discussion. Reports depend on the data entered and are not a diagnosis or an instruction to change treatment.

Explore the topic further

Common questions

Can ordinary fish oil claim the REDUCE-IT result?

No. REDUCE-IT tested prescription icosapent ethyl in a selected high-risk population on statins. That result does not establish equivalent benefit from a retail EPA/DHA capsule. [5]

Does comparing REDUCE-IT with STRENGTH prove one formulation is superior?

No. They were separate trials with different preparations and comparators, not a direct head-to-head comparison. Their different results show why “omega-3” is too broad a treatment label. [5][6]

Do higher amounts always mean greater cardiovascular benefit?

No. Benefit depends on the exact intervention and population; atrial-fibrillation signals also matter. These trials do not define a general supplement dose for everyone. [5][6]

Glossary

Terms for interpreting the comparisons.

Formulation

The exact preparation, including its ingredients, their forms and labeled amounts.

Study population

The people included in a study; their characteristics limit where its result applies.

Comparator

The placebo, treatment or condition used as the comparison.

Measured outcome

What the study evaluates, such as a symptom, laboratory result or clinical event.

Overlap

The same ingredient appearing in more than one product used together.

How was this guide researched?

Sources and limits

This AI-assisted educational guide compares the cited public references. Findings remain tied to the ingredients, preparations and populations studied. It is not a systematic review or independent medical peer review. Doserly develops a commercial tracking app. Illustrations explain concepts; app screens show example data. Report a correction with its source to Doserly support.

Explore the sources